A newly released report from the Department of Health and Human Services is raising alarm among health policy experts, who say it lacks the basic hallmarks of credible research and appears designed to cast transgender identity as a threat rather than a subject of legitimate scientific inquiry.
The document, titled "Where the Clinic Meets the Movement: Does Gender Ideology Arm Left-Wing Authoritarian Psychology?," was published by the department's Office of Public Affairs without undergoing peer review, according to NPR. Neither the underlying data nor the funding sources behind the work have been made public — departures from standard research practice that outside scientists say make the findings impossible to verify or replicate. One of the report's authors has indicated the data will be shared "soon," but no timeline has been provided.
The report arrives amid a broader pattern of actions by HHS that critics describe as an ongoing effort to erode public confidence in established medical standards for treating transgender patients. Several experts who spoke with NPR said the document goes further than simply questioning clinical approaches — it frames transgender identity itself as something suspect or even inherently dangerous.
At the center of the controversy is the involvement of Colin Wright, an evolutionary biologist affiliated with the Manhattan Institute, a right-leaning policy organization that has been heavily involved in campaigns against diversity, equity and inclusion programs and against what critics call "woke" initiatives. Wright is listed as one of the report's authors, a detail that has prompted questions about the political motivations behind the project.
Adrian Shanker, who served as a deputy assistant secretary for health policy at HHS during the Biden administration, told NPR that while the department has historically collaborated with outside experts, those partnerships followed a different model. He said the department maintained long-standing contracts with generalist science writing firms that were not politically aligned, a contrast he described as "vastly different" from the current approach.
The absence of peer review is particularly significant, experts note, because it means the report's methodology and conclusions have not been scrutinized by independent specialists in the field. Peer review is widely considered a minimum requirement for research that informs public health policy, especially when the subject matter is as politically charged as gender-affirming care.
The report's release fits into a longer arc of HHS activity targeting clinical guidelines for transgender patients. Since Robert F. Kennedy Jr. was announced as President Trump's choice to lead the department, both men have publicly emphasized their commitment to what they call "Gold Standard Scientific Research" and to making federal health agencies models of transparency. Those stated principles appear at odds with the handling of this report, which has not disclosed its data, funding or review process.
The discrepancy between the administration's stated commitment to transparency and the opacity of this particular report has become a central point of criticism. If the department's goal is to earn public trust through rigorous science, critics argue, withholding the evidence behind a consequential claim undermines that aim.
The report's framing also raises concerns about its potential impact beyond academic debate. By suggesting a possible link between gender-affirming care and political radicalization, the document could influence how policymakers, judges and regulators approach transgender health issues at a time when those questions are already the subject of intense legislative and legal battles across the country.
Experts interviewed for the story said the report characterizes transgender identity in ways that imply it is not a legitimate aspect of human diversity but rather a phenomenon that may produce extremism. That framing, they warn, could fuel stigma and provide rhetorical ammunition for restrictive policies.
The involvement of a think tank known for opposing DEI initiatives has led some observers to question whether the report was conceived as a scientific inquiry at all or as a political document dressed in research language. The fact that it was issued by the Office of Public Affairs rather than a research division has only reinforced that impression for some critics.
HHS has defended its work, and one author has promised eventual release of the data. But the lack of immediate transparency leaves the report's conclusions effectively unverifiable, a problem that scientists say is especially acute when the stakes for a vulnerable population are so high.
The episode is the latest in a series of disputes over the role of politics in federal health research. Under the current administration, HHS has repeatedly challenged mainstream clinical consensus on transgender care, and this report appears to be another step in that campaign. For researchers and advocates, the central question is whether federal health agencies will continue to ground their positions in evidence that can withstand independent scrutiny — or whether political objectives will take precedence over scientific rigor.
(0)